Among four different PTHrP peptides carrying the HLA-A24 binding motif, both the PTHrP36–44 and PTHrP102–111 peptides efficiently induced peptide-specific cytotoxic T lymphocytes from peripheral blood mononuclear cells (PBMCs) of HLA-A24+ prostate cancer patients. Here, PTHLH is linked to prostate cancer.